首页> 美国卫生研究院文献>World Journal of Cardiology >Ibutilide and novel indexes of ventricular repolarization in persistent atrial fibrillation patients
【2h】

Ibutilide and novel indexes of ventricular repolarization in persistent atrial fibrillation patients

机译:依布利特和持续性房颤患者心室复极的新指标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To examine the effect of ibutilide on novel indexes of repolarization in patients with persistent atrial fibrillation (AF).METHODS: We studied consecutive patients scheduled for elective electrical cardioversion. Intravenous ibutilide (1 + 1 mg) was administered before the electrical cardioversion while close electrocardiographic (ECG) monitoring was performed. ECG indexes such as corrected QT interval (QTc), the interval from the peak until the end of T wave (Tpe), and the Tpe/QT ratio were measured before ibutilide infusion and 10 min after the end of infusion.RESULTS: The final study population consisted of 20 patients (mean age: 67.1 ± 9.9 years, 10 men). Six patients were cardioverted pharmacologically and did not proceed to electrical cardioversion. Two patients developed short non-sustained episodes of torsades de pointes ventricular tachycardia. All but one of the aforementioned ECG indexes increased significantly after ibutilide administration. In specific, the QTc interval increased from 442 ± 29 to 471 ± 37 ms (P = 0.037), the Tpe interval in precordial leads from 96 ms (range 80-108 ms) to 101 ms (range 91-119 ms) (P = 0.021), the Tpe interval in lead II from 79 ms (range 70-88 ms) to 100 ms (range 87-104 ms) (P < 0.001), the Tpe/QT ratio in precordial leads from 0.23 ms (range 0.18-0.26 ms) to 0.26 ms (range 0.23-0.28 ms) (P = 0.028), and the Tpe interval dispersion from 25 ms (range 23-30 ms) to 35 ms (range 27-39 ms) (P = 0.012). However, the Tpe/QT ratio in lead II did not change significantly.CONCLUSION: Ibutilide increases the duration and dispersion of ventricular repolarization. The prognostic value of Tpe and Tpe/QT in the setting of drug-induced proarrhythmia needs further study.
机译:目的:探讨依布利特对持续性心房颤动(AF)患者复极新指标的影响。方法:我们研究了计划进行择期电复律的连续患者。在进行心脏电复律之前,先给予静脉使用伊布利特(1 +1 mg),同时进行密切的心电图(ECG)监测。在依布利特输注前和输注结束后10分钟测量ECG指标,例如校正的QT间隔(QTc),从峰到T波结束的间隔(Tpe)以及Tpe / QT比。研究人群包括20位患者(平均年龄:67.1±9.9岁,10位男性)。六名患者在药理上进行了心脏复律,未进行电复律。两名患者出现了短的,非持续性的扭转性尖端室性心动过速发作。依布利特施用后,除上述一项心电图指标外,所有其他指标均显着增加。具体来说,QTc间隔从442±29 ms增加到471±37 ms(P = 0.037),胸前导联的Tpe间隔从96 ms(范围80-108 ms)增加到101 ms(范围91-119 ms)(P = 0.021),导联II中的Tpe间隔从79 ms(范围70-88 ms)到100 ms(范围87-104 ms)(P <0.001),胸前导联中的Tpe / QT比从0.23 ms(范围0.18) -0.26毫秒)至0.26毫秒(范围0.23-0.28毫秒)(P = 0.028),以及Tpe间隔从25毫秒(范围23-30毫秒)到35毫秒(范围27-39毫秒)(P = 0.012) 。然而,铅II的Tpe / QT比值并没有明显改变。结论:伊布利特增加了心室复极的持续时间和分散性。 Tpe和Tpe / QT在药物性心律失常中的预后价值尚待进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号